Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Multiple Sclerosis

Free Subscription 12.09.2022 7 Mult Scler 1 Neurologia (Engl Ed)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Mult Scler

1. VAN LIEROP ZY, Noteboom S, Steenwijk MD, van Dam M, et al
   Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis.
   Mult Scler. 2022 Sep 3:13524585221118676. doi: 10.1177/13524585221118676.
   PubMed         Abstract available
   
   
2. PAUWELS A, Van Schependom J, Devolder L, Van Remoortel A, et al
   Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
   Mult Scler. 2022;28:1685-1696.
   PubMed         Abstract available
   
   
3. FORD CC, Cohen JA, Goodman AD, Lindsey JW, et al
   Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.
   Mult Scler. 2022;28:1729-1743.
   PubMed         Abstract available
   
   
4. HARDY TA, Guo Y, Flanagan EP, Lucchinetti CF, et al
   The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions.
   Mult Scler. 2022;28:1710-1718.
   PubMed         Abstract available
   
   
5. CAPANNA M, Signori A, Sormani MP
   Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trials.
   Mult Scler. 2022;28:1744-1751.
   PubMed         Abstract available
   
   
6. ZARGHAMI A, van der Mei I, Hussain MA, Claflin SB, et al
   Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination.
   Mult Scler. 2022;28:1793-1807.
   PubMed         Abstract available
   
   
7. GRAF J, Ng HS, Zhu F, Zhao Y, et al
   Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits.
   Mult Scler. 2022;28:1825-1828.
   PubMed         Abstract available
   
   

   
   Neurologia (Engl Ed)

8. MARTIN-AGUILAR L, Presas-Rodriguez S, Rovira A, Capellades J, et al
   Gadolinium-enhanced brain lesions in multiple sclerosis relapse.
   Neurologia (Engl Ed). 2022;37:557-563.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: